Similarly, tumor specific CD8 T cells displayed a reduced killing ability toward GL261-B7H4 cells than to GL261-mock cells at optimal effector:target ratios (5:1 and 10:1) (Fig. 6b). This evidence concerns the gene CD8A and neoplasm.